Erratum: Editor's note: Inhibition of platelet-derived growth factor–mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571 (Clin Cancer Res (2019) 8:3584–91))

Eric C. McGary, Kristy Weber, Lisa Mills, Michelle Doucet, Valerie Lewis, Dina Chelouche Lev, Isaiah J Fidler, Menashe Bar-Eli

Research output: Contribution to journalComment/debatepeer-review

Abstract

The editors are publishing this note to alert readers to a concern about this article (1): Figure 2 is missing a splice line in the lanes between PDGF-BB 50 and 10, and the original data are not available for review. Reference 1. McGary EC, Weber K, Mills L, Doucet M, Lewis V, Lev DC, et al. Inhibition of platelet-derived growth factor-mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571. Clin Cancer Res 2002;8:3584–91.

Original languageEnglish (US)
Pages (from-to)3196
Number of pages1
JournalClinical Cancer Research
Volume25
Issue number10
DOIs
StatePublished - 2019

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Erratum: Editor's note: Inhibition of platelet-derived growth factor–mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571 (Clin Cancer Res (2019) 8:3584–91))'. Together they form a unique fingerprint.

Cite this